MARCUS CORPORATION (MCS) Fundamental Analysis & Valuation

NYSE:MCS • US5663301068

Current stock price

19.39 USD
+0.25 (+1.31%)
At close:
19.39 USD
0 (0%)
After Hours:

This MCS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MCS Profitability Analysis

1.1 Basic Checks

  • In the past year MCS was profitable.
  • In the past year MCS had a positive cash flow from operations.
  • In multiple years MCS reported negative net income over the last 5 years.
  • Each year in the past 5 years MCS had a positive operating cash flow.
MCS Yearly Net Income VS EBIT VS OCF VS FCFMCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • MCS's Return On Assets of 1.25% is fine compared to the rest of the industry. MCS outperforms 70.89% of its industry peers.
  • MCS's Return On Equity of 2.77% is fine compared to the rest of the industry. MCS outperforms 72.15% of its industry peers.
  • With a decent Return On Invested Capital value of 2.01%, MCS is doing good in the industry, outperforming 68.35% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for MCS is significantly below the industry average of 159.10%.
Industry RankSector Rank
ROA 1.25%
ROE 2.77%
ROIC 2.01%
ROA(3y)0.63%
ROA(5y)-0.58%
ROE(3y)1.41%
ROE(5y)-1.59%
ROIC(3y)2.39%
ROIC(5y)N/A
MCS Yearly ROA, ROE, ROICMCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.67%, MCS is in the better half of the industry, outperforming 67.09% of the companies in the same industry.
  • MCS's Operating Margin of 2.86% is fine compared to the rest of the industry. MCS outperforms 67.09% of its industry peers.
  • In the last couple of years the Operating Margin of MCS has grown nicely.
  • Looking at the Gross Margin, with a value of 38.68%, MCS is in line with its industry, outperforming 46.84% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MCS has grown nicely.
Industry RankSector Rank
OM 2.86%
PM (TTM) 1.67%
GM 38.68%
OM growth 3Y25.06%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y12.47%
MCS Yearly Profit, Operating, Gross MarginsMCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

3

2. MCS Health Analysis

2.1 Basic Checks

  • MCS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for MCS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, MCS has less shares outstanding
  • Compared to 1 year ago, MCS has a worse debt to assets ratio.
MCS Yearly Shares OutstandingMCS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
MCS Yearly Total Debt VS Total AssetsMCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • MCS has an Altman-Z score of 1.71. This is a bad value and indicates that MCS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of MCS (1.71) is better than 62.03% of its industry peers.
  • The Debt to FCF ratio of MCS is 172.18, which is on the high side as it means it would take MCS, 172.18 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 172.18, MCS is in the better half of the industry, outperforming 60.76% of the companies in the same industry.
  • MCS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of MCS (0.37) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 172.18
Altman-Z 1.71
ROIC/WACC0.23
WACC8.87%
MCS Yearly LT Debt VS Equity VS FCFMCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • MCS has a Current Ratio of 0.40. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.40, MCS is doing worse than 86.08% of the companies in the same industry.
  • MCS has a Quick Ratio of 0.40. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MCS has a worse Quick ratio (0.40) than 84.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
MCS Yearly Current Assets VS Current LiabilitesMCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

5

3. MCS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 253.85% over the past year.
  • The Revenue has been growing slightly by 3.11% in the past year.
  • The Revenue has been growing by 26.12% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)253.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%533.33%
Revenue 1Y (TTM)3.11%
Revenue growth 3Y3.84%
Revenue growth 5Y26.12%
Sales Q2Q%2.75%

3.2 Future

  • Based on estimates for the next years, MCS will show a very strong growth in Earnings Per Share. The EPS will grow by 31.47% on average per year.
  • The Revenue is expected to grow by 3.38% on average over the next years.
EPS Next Y41.4%
EPS Next 2Y39.74%
EPS Next 3Y31.47%
EPS Next 5YN/A
Revenue Next Year6.35%
Revenue Next 2Y4.74%
Revenue Next 3Y3.38%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MCS Yearly Revenue VS EstimatesMCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
MCS Yearly EPS VS EstimatesMCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4

5

4. MCS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 48.48, MCS can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of MCS indicates a somewhat cheap valuation: MCS is cheaper than 70.89% of the companies listed in the same industry.
  • MCS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.18.
  • With a Price/Forward Earnings ratio of 34.28, MCS can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, MCS is valued a bit cheaper than 72.15% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.96, MCS is valued at the same level.
Industry RankSector Rank
PE 48.48
Fwd PE 34.28
MCS Price Earnings VS Forward Price EarningsMCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 86.08% of the companies in the same industry are more expensive than MCS, based on the Enterprise Value to EBITDA ratio.
  • MCS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MCS is cheaper than 60.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF 603.46
EV/EBITDA 8.01
MCS Per share dataMCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • MCS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of MCS may justify a higher PE ratio.
  • MCS's earnings are expected to grow with 31.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.17
PEG (5Y)N/A
EPS Next 2Y39.74%
EPS Next 3Y31.47%

4

5. MCS Dividend Analysis

5.1 Amount

  • MCS has a Yearly Dividend Yield of 1.66%.
  • MCS's Dividend Yield is rather good when compared to the industry average which is at 9.59. MCS pays more dividend than 92.41% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, MCS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.66%

5.2 History

  • The dividend of MCS decreases each year by -14.68%.
  • MCS has paid a dividend for at least 10 years, which is a reliable track record.
  • MCS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-14.68%
Div Incr Years3
Div Non Decr Years3
MCS Yearly Dividends per shareMCS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 72.16% of the earnings are spent on dividend by MCS. This is not a sustainable payout ratio.
DP72.16%
EPS Next 2Y39.74%
EPS Next 3Y31.47%
MCS Yearly Income VS Free CF VS DividendMCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M
MCS Dividend Payout.MCS Dividend Payout, showing the Payout Ratio.MCS Dividend Payout.PayoutRetained Earnings

MCS Fundamentals: All Metrics, Ratios and Statistics

MARCUS CORPORATION

NYSE:MCS (4/14/2026, 4:15:00 PM)

After market: 19.39 0 (0%)

19.39

+0.25 (+1.31%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners82.5%
Inst Owner Change0%
Ins Owners5.91%
Ins Owner Change9.04%
Market Cap596.82M
Revenue(TTM)758.46M
Net Income(TTM)12.69M
Analysts84.44
Price Target23.87 (23.1%)
Short Float %3.37%
Short Ratio5.12
Dividend
Industry RankSector Rank
Dividend Yield 1.66%
Yearly Dividend0.29
Dividend Growth(5Y)-14.68%
DP72.16%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-25
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100.52%
Min EPS beat(2)1.25%
Max EPS beat(2)199.79%
EPS beat(4)3
Avg EPS beat(4)51.53%
Min EPS beat(4)-10.24%
Max EPS beat(4)199.79%
EPS beat(8)4
Avg EPS beat(8)-305.59%
EPS beat(12)6
Avg EPS beat(12)-202.02%
EPS beat(16)8
Avg EPS beat(16)-143.28%
Revenue beat(2)1
Avg Revenue beat(2)0.56%
Min Revenue beat(2)-3.13%
Max Revenue beat(2)4.25%
Revenue beat(4)3
Avg Revenue beat(4)2.04%
Min Revenue beat(4)-3.13%
Max Revenue beat(4)5.29%
Revenue beat(8)6
Avg Revenue beat(8)3.09%
Revenue beat(12)10
Avg Revenue beat(12)2.69%
Revenue beat(16)14
Avg Revenue beat(16)4.61%
PT rev (1m)1.74%
PT rev (3m)-2.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.01%
EPS NY rev (1m)1.82%
EPS NY rev (3m)-15.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.72%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 48.48
Fwd PE 34.28
P/S 0.79
P/FCF 603.46
P/OCF 7.09
P/B 1.3
P/tB 1.56
EV/EBITDA 8.01
EPS(TTM)0.4
EY2.06%
EPS(NY)0.57
Fwd EY2.92%
FCF(TTM)0.03
FCFY0.17%
OCF(TTM)2.74
OCFY14.11%
SpS24.64
BVpS14.86
TBVpS12.42
PEG (NY)1.17
PEG (5Y)N/A
Graham Number11.56
Profitability
Industry RankSector Rank
ROA 1.25%
ROE 2.77%
ROCE 2.55%
ROIC 2.01%
ROICexc 2.07%
ROICexgc 2.28%
OM 2.86%
PM (TTM) 1.67%
GM 38.68%
FCFM 0.13%
ROA(3y)0.63%
ROA(5y)-0.58%
ROE(3y)1.41%
ROE(5y)-1.59%
ROIC(3y)2.39%
ROIC(5y)N/A
ROICexc(3y)2.51%
ROICexc(5y)N/A
ROICexgc(3y)2.79%
ROICexgc(5y)N/A
ROCE(3y)3.03%
ROCE(5y)N/A
ROICexgc growth 3Y33.19%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.87%
ROICexc growth 5YN/A
OM growth 3Y25.06%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y12.47%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 172.18
Debt/EBITDA 1.82
Cap/Depr 118.55%
Cap/Sales 10.97%
Interest Coverage 2.02
Cash Conversion 91.65%
Profit Quality 7.79%
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 1.71
F-Score6
WACC8.87%
ROIC/WACC0.23
Cap/Depr(3y)97.57%
Cap/Depr(5y)74.26%
Cap/Sales(3y)9.02%
Cap/Sales(5y)7.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)253.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%533.33%
EPS Next Y41.4%
EPS Next 2Y39.74%
EPS Next 3Y31.47%
EPS Next 5YN/A
Revenue 1Y (TTM)3.11%
Revenue growth 3Y3.84%
Revenue growth 5Y26.12%
Sales Q2Q%2.75%
Revenue Next Year6.35%
Revenue Next 2Y4.74%
Revenue Next 3Y3.38%
Revenue Next 5YN/A
EBIT growth 1Y-5.7%
EBIT growth 3Y29.87%
EBIT growth 5YN/A
EBIT Next Year468.05%
EBIT Next 3Y246.74%
EBIT Next 5YN/A
FCF growth 1Y-96%
FCF growth 3Y-74.02%
FCF growth 5YN/A
OCF growth 1Y-18.99%
OCF growth 3Y-3.33%
OCF growth 5YN/A

MARCUS CORPORATION / MCS Fundamental Analysis FAQ

What is the fundamental rating for MCS stock?

ChartMill assigns a fundamental rating of 5 / 10 to MCS.


What is the valuation status of MARCUS CORPORATION (MCS) stock?

ChartMill assigns a valuation rating of 5 / 10 to MARCUS CORPORATION (MCS). This can be considered as Fairly Valued.


How profitable is MARCUS CORPORATION (MCS) stock?

MARCUS CORPORATION (MCS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for MCS stock?

The Price/Earnings (PE) ratio for MARCUS CORPORATION (MCS) is 48.48 and the Price/Book (PB) ratio is 1.3.


Can you provide the dividend sustainability for MCS stock?

The dividend rating of MARCUS CORPORATION (MCS) is 4 / 10 and the dividend payout ratio is 72.16%.